Pontificia Universidade Catolica de Sao Paulo
14
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
50%
7 trials in Phase 3/4
20%
2 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium
Role: lead
Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children
Role: lead
Quality of Recovery Under Low or Standard Pneumoperitoneum Pressure
Role: lead
Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade
Role: lead
Low-pressure vs Standard-pressure in Laparoscopic Cholecystectomy
Role: lead
Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration
Role: lead
Evaluation of Local Doxycycline in Smokers With Chronic Periodontitis
Role: collaborator
Quality of Recovery After General or Spinal Anesthesia for Inguinal Hernia Repair
Role: lead
QUALITY OF RECOVERY AFTER INTRAOPERATIVE MORPHINE OR METHADONE
Role: lead
Low Doses of Ketamine and Postoperative Quality of Recovery
Role: lead
Lips and Tongue of Mouth Breathing Children
Role: lead
Facial Type Determination Through Cephalometry, Anthropometry and Facial Analysis
Role: lead
Chloral Hydrate to Perform Auditory Brainstem Response (ABR)
Role: lead
Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome
Role: lead
All 14 trials loaded